These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6774172)

  • 1. Plasma hormones in pre- and postmenopausal breast cancer.
    Drafta D; Schindler AE; Milcu SM; Keller E; Stroe E; Horodniceanu E; Bălănescu I
    J Steroid Biochem; 1980 Jul; 13(7):793-802. PubMed ID: 6774172
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Dopa effect on prolactin, follicle-stimulating hormone, and luteinizing hormone in women with advanced breast cancer: a preliminary report.
    Dickey RP; Minton JP
    Am J Obstet Gynecol; 1972 Sep; 114(2):267-9. PubMed ID: 4635766
    [No Abstract]   [Full Text] [Related]  

  • 6. Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid peptide hormone levels.
    Vihko R; Jänne O; Kontula K; Syrjälä P
    Int J Cancer; 1980 Jul; 26(1):13-21. PubMed ID: 6786991
    [No Abstract]   [Full Text] [Related]  

  • 7. [Steroid receptor levels in human breast carcinomas in relation to serum hormone levels in postmenopausal patients (author's transl)].
    Reiner G; Bieglmayer C; Jakesz R; Kees A; Kolb R; Spona J
    Wien Klin Wochenschr; 1981 May; 93(11):339-42. PubMed ID: 6791390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
    Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
    Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of thyrotropin-releasing hormone on the postmenopausal female.
    Lee SG; Lundy LE; Kashef M; Dorn J
    Obstet Gynecol; 1975 Jan; 45(1):25-6. PubMed ID: 803307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones and the pathophysiology of fibrocystic mastopathy: elevated luteinizing hormone levels.
    Golinger RC; Krebs J; Fisher ER; Danowski TS
    Surgery; 1978 Aug; 84(2):212-5. PubMed ID: 684613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary observations on alterations in prolactin, gonadotropins, E2-17B & progesterone in patients with breast cancer.
    Dash RJ; Behera D; Khanchi RK; Singh K
    Indian J Med Res; 1987 Dec; 86():749-54. PubMed ID: 3131240
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer.
    Bird CE; Cook S; Owen S; Sterns EE; Clark AF
    Oncology; 1981; 38(6):365-8. PubMed ID: 6795556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma progesterone, estradiol and prolactin concentrations and breast cancer in pre and postmenopausal women.
    Raheem SN; Atoum M; Al-Hourani H; Rasheed M; Nimer N; Almuhrib T
    Neoplasma; 2010; 57(1):74-8. PubMed ID: 19895176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.
    Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
    Cancer Res; 1977 Dec; 37(12):4655-9. PubMed ID: 922746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
    Sipinen S; Lähteenmäki P; Luukkainen T
    Acta Obstet Gynecol Scand; 1980; 59(2):149-53. PubMed ID: 6773291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone concentrations in postmenopausal patients with breast cancer.
    Jones MK; Ramsay ID; Booth M; Collins WP
    Clin Oncol; 1977 Jun; 3(2):177-81. PubMed ID: 872471
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating hormone concentrations in women with breast cancer.
    McFadyen IJ; Forrest AP; Prescott RJ; Golder MP; Groom GV; Fahmy DR; Griffiths K
    Lancet; 1976 May; 1(7969):1100-2. PubMed ID: 57508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma hormones in parous, nulliparous and postmenopausal Japanese women.
    Hill P; Garbaczewski L; Kasumi K; Wynder EL
    Cancer Lett; 1986 Nov; 33(2):131-6. PubMed ID: 3098404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
    McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K
    Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.